We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A 90-year-old woman was referred by her ophthalmologist ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The trial achieved its primary endpoint of proptosis ...

Findings showed a statistically significant reduction in proptosis in the linsitinib 150mg twice daily group, with a proptosis responder rate of 52% at week 24. Topline results were announced from a ...

Credit: Getty Images. Tepezza is a human insulin-like growth factor-1 receptor inhibitor. Tepezza ® (teprotumumab-trbw) significantly reduced proptosis in adults with chronic thyroid eye disease (TED) ...

The differential diagnosis of childhood proptosis includes several potential life-threatening or vision-threatening diseases that must not be missed. It includes the following: Orbital lymphangioma is ...

Of the 655 patients enrolled in this study, 89 (13.5%) (95% confidence interval [CI] 15%-10%) presented with unilateral exophthalmos. Exophthalmometer values in the ...

Bulging Eyes refers to the abnormal protrusion or sticking out of one or both eyeballs from the eye socket. Normally, there should be no visible white between the colored part of the eye and the upper ...

Dr. Mark A. Matza (Medicine): An 18-year-old man was evaluated at this hospital because of diplopia and proptosis of the left eye. The patient had been well until approximately 33 months before this ...

DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced new pooled efficacy data from the Phase 2 and 3 clinical trials of TEPEZZA™ (teprotumumab-trbw) showing that the ...